Down 52%, Is TransMedics Stock a Buy on the Dip?

Sales growth is tapering off for this provider of delivery services for transplant organs.From the beginning of 2024 through Aug. 23, shares of TransMedics (TMDX 0.56%) stock soared by 123% -- but the good times didn't last. A third-quarter earnings miss sent shares of the organ-transplant equipment and service provider reeling. By lunchtime on Nov. 7, the stock was 51.5% below its previous peak.Hospitals and organ transplant centers increasingly rely on TransMedics' proprietary organ care system (OCS). Is ...